Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Operating Leases (2022 - 2025)

Historic Operating Leases for NeuroPace (NPCE) over the last 4 years, with Q3 2025 value amounting to $12.4 million.

  • NeuroPace's Operating Leases fell 1264.67% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year decrease of 1264.67%. This contributed to the annual value of $12.0 million for FY2024, which is 1347.18% down from last year.
  • According to the latest figures from Q3 2025, NeuroPace's Operating Leases is $12.4 million, which was down 1264.67% from $12.9 million recorded in Q2 2025.
  • NeuroPace's Operating Leases' 5-year high stood at $16.5 million during Q1 2023, with a 5-year trough of $6.2 million in Q2 2022.
  • Its 4-year average for Operating Leases is $13.4 million, with a median of $14.2 million in 2024.
  • Per our database at Business Quant, NeuroPace's Operating Leases soared by 16242.9% in 2023 and then crashed by 1347.18% in 2024.
  • Quarter analysis of 4 years shows NeuroPace's Operating Leases stood at $15.4 million in 2022, then fell by 10.53% to $13.8 million in 2023, then decreased by 13.47% to $12.0 million in 2024, then grew by 4.02% to $12.4 million in 2025.
  • Its Operating Leases was $12.4 million in Q3 2025, compared to $12.9 million in Q2 2025 and $13.4 million in Q1 2025.